share_log

HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target

Benzinga ·  Mar 11 10:37

HC Wainwright & Co. analyst Joseph Pantginis maintains Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment